An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Yafei Liu(Osaka International University), Wai Tuck Soh(Osaka International University), Jun-ichi Kishikawa(Protein Research Foundation), Mika Hirose(Protein Research Foundation), Emi E. Nakayama(The University of Osaka), Songling Li(The University of Osaka), Miwa Sasai(The University of Osaka), Tatsuya Suzuki(The University of Osaka), Asa Tada(Osaka International University), Akemi Arakawa(Osaka International University), Sumiko Matsuoka(The University of Osaka), Kanako Akamatsu(The University of Osaka), M. Matsuda(Protein Research Foundation), Chikako Ono(The University of Osaka), Shiho Torii(The University of Osaka), Kazuki Kishida(Osaka International University), Hui Jin(The University of Osaka), Wataru Nakai(Osaka International University), Noriko Arase(The University of Osaka), Atsushi Nakagawa(Protein Research Foundation), Maki Matsumoto(Futaba (Japan)), Yukoh Nakazaki(Futaba (Japan)), Yasuhiro Shindo(Futaba (Japan)), Masako Kohyama(Osaka International University), Keisuke Tomii(Kobe City Medical Center General Hospital), Koichiro Ohmura(Kobe City Medical Center General Hospital), Shiro Ohshima(Osaka Minami Medical Center), Toru Okamoto(Osaka International Cancer Institute), Masahiro Yamamoto(Osaka International Cancer Institute), Hironori Nakagami(The University of Osaka), Yoshiharu Matsuura(Osaka International Cancer Institute), Atsushi Nakagawa(Protein Research Foundation), Takayuki Kato(Protein Research Foundation), Masato Okada(Osaka International Cancer Institute), Daron M. Standley(Osaka International Cancer Institute), Tatsuo Shioda(Osaka International Cancer Institute), Hisashi Arase(Osaka International Cancer Institute)
Cited by 289Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis